Clinical Trials at Hospital Central
During the past decade, Hospital Central conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 6 clinical trials were completed, i.e. on
average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Hospital Central" #1 sponsor was "Kirby Institute" with 2 trials, followed by "Pfizer" with 2 trials
sponsored, "Argentinian Intensive Care Society" with 1 trials sponsored, "BHR Pharma, LLC" with 1 trials sponsored and "Cubist Pharmaceuticals LLC"
with 1 trials sponsored. Other sponsors include -1 different institutions and
companies that sponsored additional 9 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Central"
#1 collaborator was "Abbott" with 1 trials as a collaborator, "ICON plc" with 1 trials as a collaborator, "Medidata Solutions" with 1 trials as a collaborator, "Merck Sharp & Dohme LLC" with 1 trials as a collaborator and "Ministry of Public Health, Argentina" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were
collaborators in the rest 10 trials.
Clinical Trials Conditions at Hospital Central
According to Clinical.Site data, the most researched conditions in "Hospital Central" are
"HIV Infections" (3 trials), "Cardiovascular Disease" (2 trials), "Acute Respiratory Failure" (1 trials), "Brain Injuries" (1 trials) and "Cardiovascular Diseases" (1 trials). Many other conditions were trialed in "Hospital Central" in a lesser frequency.
Clinical Trials Intervention Types at Hospital Central
Most popular intervention types in "Hospital Central" are "Drug" (7 trials) and "Behavioral" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "bococizumab (PF-04950615)" (2 trials), "2N(t)RTI" (1 trials), "Apabetalone" (1 trials) and "Atorvastatin" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Hospital Central
The vast majority of trials in "Hospital Central" are
11 trials for "All" genders.
Clinical Trials Status at Hospital Central
Currently, there are NaN active trials in "Hospital Central".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 7 completed trials in Hospital Central,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Hospital Central, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 1 trials that are defined as “Not Applicable".